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Summary and Implications 
 Oral meloxicam was administered to sows post-
farrowing to investigate a novel route of providing analgesia 
to processed piglets via translactational drug transfer. 
Physiologic indicators of piglet pain were analyzed to 
determine the effects on pain control.  An effective 
meloxicam dosage was reached in 4/5 sow litters with no 
adverse clinical effects.  Both piglet cortisol and cranial skin 
temperature measured by infrared thermography indicated 
significant differences in pain biomarkers between treatment 
groups. This  study  demonstrates  the  successful  transfer  
of  meloxicam  in  sow’s  milk  and description of 
physiologic pain indicators after processing.  It provides the 
foundation for future research into refining a novel, 
efficacious, and practical method of providing analgesia to 
piglets during processing.  
 
Introduction 
 Consumers are increasingly concerned with the well-
being and quality of life of animals raised for food. One 
particular area of growing concern is the management of 
pain associated with routine animal husbandry practices 
such as castration and tail docking in piglets.  
 Objective, repeatable methods of measuring pain are 
also needed.  In previous studies, both cortisol and 
Substance P have been used to assess pain in livestock.  
Additionally, infrared thermography, which shows a 
decreased temperature in anatomical extremities during 
pain, has been used to describe these processes in livestock.   
 Presently, there are no validated and approved drug 
regimens to alleviate pain in swine. It is clear the US needs 
pain mitigation for routine use in swine production systems  
that will be safe for both handler and animal, efficacious,  
 
easily administered, and that maintains  domestic and export 
markets. 
 
     Materials and Methods 
 Ten sows were selected, based on farrowing date, to 
receive either meloxicam (30 mg/kg) or equivalent volume 
of whey protein placebo in their daily feedings starting four 
days post-farrowing and continuing for three consecutive 
days.  Blood and milk samples were collected from the sows 
at 12 hour intervals beginning directly prior to first feeding 
for four days through the end of the study.  On Day 5 post 
farrowing, three boars and three gilts from each litter were 
castrated or sham castrated, tail docked and given an iron 
injection. Piglet blood samples were collected immediately 
before processing, and then at predetermined times over an 
84 hour period until the end of the study. Additionally, 
infrared thermography (IRT) images of the surface of the 
piglet’s cranium, left and right ears, and snout were captured 
at each piglet blood collection point. Eight days post- 
farrowing, tissue samples were collected at necropsy from 
sows and piglets to determine potential toxic effects of the 
prolonged high meloxicam dosage. 
 
Results and Discussion 
 Piglet plasma from each litter was tested to confirm the 
presence of meloxicam using a validated HPLC- MS 
technique. Meloxicam was found in all of the litters in the 
treatment group (Mean ± SEM:285 ± 61 ng/mL).  Levels 
reached concentrations known to be effective in equine 
(EC50) in 4 of the 5 treatment litters (Figure 1).This value 
was extrapolated because the EC 50 in swine in currently 
unknown.   
 No adverse clinical effects were noted in meloxicam 
treated sows and piglets.  However, on histopathology 
exam, subacute gastritis was noted in 2/5 meloxicam treated 
sows.  Similar lesions and gross button ulcers were seen in 
10/11 of piglets born to these sows.   
     IRT demonstrated a significantly lower cranial skin 
temperature in placebo vs. meloxicam treated piglets 
differences in cranial skin temperature (p<0.0001). 
Temperature decreases are seen due to pain and stress 
causing sympathetic nervous system activation. This leads 
to vasoconstriction, and thereby temperature decrease in the 
periphery of the body.  However, there was no significant 
difference between snout and both ear temperatures. (Table 
1.) 
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 Meloxicam-treated piglets had a significantly lower  
percentage change from baseline levels of cortisol than 
placebo-treated piglets (p<0.0001) at one hour post-
castration. However, differences became insignificant at 
subsequent time points. 
 Measurement of Substance P indicated no difference 
between placebo and meloxicam treated groups (p=0.8685).  
 This  study  demonstrates  the  successful  transfer  of  
meloxicam  in  sow’s  milk  and description of physiologic 
pain indicators.  It provides the foundation for future  
 
 
research into refining a novel, efficacious, and practically 
administered analgesia method. 
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Figure 1. Piglet plasma meloxicam concentrations. 
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Table 1. Calculated pain biomarker parameters for piglets receiving via their dam’s milk either lactose placebo (30 
mg/kg to the sow) or meloxicam (30 mg/kg to the sow) mixed in feed and administered per os. Treatment was 
administered 24 h prior to processing and continued for three days.   
 
 
Treatment (Piglets received via milk from sow treated with meloxicam or placebo) 
       Experimental Group Calculated Means  P VALUES
Sex             CAST            SHAM                 (model adjusted)
Treatment Placebo Meloxicam Placebo Meloxicam
Parameter Time Treatment1 Time*Treatment
Average Cortisol 
(ng/mL)
48.9 50.99 43.71 44.53 <0.0001 0.5947 0.0074
% change cortisol 36.37 11.6 50.72 -2.9 <0.0001 0.1196 <0.0001
Average Substance P 
(pg/mL)
89.24 95.53 81.13 96.63 0.2323 0.2367 0.8685
% change SubP 3.85 6.69 4.52 3.56 0.1196 0.8913 0.8879
Left Ear Temp (˚C) 32.06 32.44 32.56 32.35 <0.0001 0.0001 0.6108
Right Ear Temp (˚C) 34.37 33.83 34.07 33.85 <0.0001 0.9544 0.7653
Snout Temp (˚C) 31.56 32.43 32.1 31.93 <0.0001 0.5318 0.2337
Cranium Temp (˚C) 37.35 37.55 37.35 37.47 <0.0001 0.8615 0.1571
